Coagulation indicators in patients with paroxysmal atrial fibrillation: Effects of electric and pharmacologic cardioversion

American Heart Journal

Volumn 140, Issue 3, 2000, Pages 423-429

  Giansante, Carlo ^a   Fiotti, Nicola ^a   Miccio, Maddalena ^b   Altamura, Nicola ^a   Salvi, Rosamaria ^b   Guarnieri, Gianfranco ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; FIBRINOPEPTIDE A; PROPAFENONE; QUINIDINE SULFATE; VERAPAMIL;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CARDIOVERSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033828735     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2000.108520     Document Type: Article

References (39)

1. Epidemiological assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study
2. Atrial fibrillation: A major contributor to stroke in the elderly: The Framingham study
3. Aetiology, pathophysiology and clinical features of atrial fibrillation
4. Cardioversion of atrial fibrillation
5. Prevention of embolic events after cardioversion of atrial fibrillation. Current and evolving strategies
6. Antithrombotic therapy in atrial fibrillation
7. Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy
8. Biochemical markers of coagulation activation in mitral stenosis, atrial fibrillation, and cardiomyopathy
9. Platelet activation is not involved in acceleration of the coagulation system in acute cardioembolic stroke with nonvalvular atrial fibrillation
10. Increased markers of thrombogenesis in chronic atrial fibrillation: Effects of warfarin treatment
11. Fibrin p-dimer and β-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin
12. Kinetic characterization of saturable pathway for rapid clearance of circulating fibrin monomer
13. Disposition of human fibrinopeptide A in normal and nephrectomized rabbits
14. Fibrin D-dimer: A useful clinical marker of thrombogenesis?
15. Fibrinopeptide A: A marker of acute coronary thrombosis
16. Is raised plasma fibrinopeptide A a marker of acute coronary insufficiency?
17. Plasmatic parameters of fibrin formation and degradation in cancer patients: Correlation between fibrinopeptide A and D-dimer
18. Plasma level changes of fibrinopeptide A after uncomplicated coronary angioplasty
19. Platelet function, thrombin and fibrinolytic activity in patients with heart failure
20. Fibrinopeptide A as thrombotic risk marker in diabetic and atherosclerotic coronary vasculopathy
21. D-dimer and coagulation in patients with mechanical prosthetic heart valves
22. Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism
23. D-dimer testing and acute venous thromboembolism. A shortcut to accurate diagnosis?
24. Fibrinolytic response and fibrin fragment D-dimer levels in patients with deep venous thrombosis
25. Fibrinogen, D-dimer and thrombin-antithrombin complexes in a random population sample: Relationship with other cardiovascular risk factors
26. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: A study in patients with paroxysmal atrial fibrillation
27. Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: Effects of cardioversion to sinus rhythm
28. Activation of the hemostatic mechanism after pharmacological cardioversion of acute nonvalvular atrial fibrillation
29. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: Final results of a prospective 4.5-year study
30. Cardioversion guided by transesophageal echocardiography: The ACUTE Pilot Study. A randomized, controlled trial. Assessment of cardioversion using transesophageal echocardiography
31. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study
32. Cardioversion in atrial fibrillation. Results and complications in 1,152 prospective patients
33. Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm
34. Use of cardiac troponin T rapid assay in the diagnosis of a myocardial injury secondary to electrical cardioversion
35. Measurement of fibrinolytic components in human tissue
36. Enhanced blood fibrinolytic activity after direct-current cardioversion
37. Relationship between electrical shock and fibrinolysis
38. The management of chronic atrial fibrillation: Indication and method of cardioversion to sinus rhythm
39. Electrical reversion of cardiac arrhythmias